tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
LogicBio Therapeutics's activity chart (see below) currently has 17 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 265 days.
Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 22-Aug-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Dec-2021
4 years 2 months ago
(22-Aug-2022)
2/2 (100%)
$-61.4 (-79.33%)
162
Buy
$2
$-5.93 (-74.78%)
$16
4 years 5 months 11 days ago
(10-May-2022)
3/3 (100%)
$1.54 (334.78%)
379
Buy
$8
$5.93 (286.47%)
4 years 11 months 5 days ago
(17-Nov-2021)
0/1 (0%)
$4.53 (130.55%)
$26
$17.37 (201.27%)
7 years 3 months 6 days ago
(16-Jul-2019)
1/1 (100%)
$26 (0.00%)
519
What is LOGC (LogicBio Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on LOGC (LogicBio Therapeutics)?
Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?
